Amedeo Smart

Free Medical Literature Service

 

Amedeo

Anemia
  Free Subscription

Articles published in
Blood
    February 2026
  1. BALBIN-CUESTA G, Drysdale C, Kerpet C, Yu L, et al
    p27Kip1 regulates gamma-globin production.
    Blood. 2026;147:973-986.
    >> Share

    January 2026
  2. SOHAIL H, Collins JE, Chan KH, Alamgir MA, et al
    A Retrospective, Real-World Study of IV Iron Use to Treat Iron deficiency Anemia During Acute Infection.
    Blood. 2026 Jan 27:blood.2025031965. doi: 10.1182/blood.2025031965.
    >> Share

  3. GUMMADI YK, Trottier AM
    Elevated serum erythropoietin level in JAK2+ polycythemia vera with small vessel Budd-Chiari syndrome.
    Blood. 2026;147:316.
    >> Share

    December 2025
  4. RUITER TJJ, van Oirschot BA, Waanders E, Koop K, et al
    NMNAT3 deficiency: a novel red blood cell enzymopathy causing hemolysis by altering NAD levels and glycolysis.
    Blood. 2025;146:3246-3249.
    >> Share

  5. AN X
    Rbm38 binds Fech pre-mRNA to prevent anemia and porphyria.
    Blood. 2025;146:3016-3017.
    >> Share

    November 2025
  6. CHALUMEAU A, Bou Dames M, Fontana L, Amistadi S, et al
    A prime editing strategy to rewrite the gamma-globin promoters and reactivate fetal hemoglobin for sickle cell disease.
    Blood. 2025;146:2641-2655.
    >> Share

  7. WILKS A, Steinberg MH, Frangoul H
    Gene therapy for HbSC disease and other compound heterozygous sickle hemoglobinopathies: a time for inclusion.
    Blood. 2025;146:2385-2391.
    >> Share

    October 2025
  8. RONCADOR M, Bernard E, Hasserjian R, Boultwood J, et al
    A precision medicine approach to the myelodysplastic syndrome with isolated deletion 5q, 50 years after its discovery.
    Blood. 2025;146:1883-1896.
    >> Share

    September 2025
  9. RODRIGUES F, Hardouin G, El Hoss S, Ghoul A, et al
    VEXAS anemia is a mosaic erythroblastopenia.
    Blood. 2025 Sep 19:blood.2025029081. doi: 10.1182/blood.2025029081.
    >> Share

  10. FALABREGUE M, Aurrand C, Cazaulon L, Boussetta N, et al
    Intestinal hepcidin overexpression promotes iron deficiency anemia and counteracts iron overload via DMT1 downregulation.
    Blood. 2025 Sep 9:blood.2025028370. doi: 10.1182/blood.2025028370.
    >> Share

    August 2025
  11. SILVESTRI L
    When TNFalpha is out, IFN-gamma drives anemia of inflammation.
    Blood. 2025;146:908-910.
    >> Share

  12. BRUNNER PM
    The landscape of disease: mapping aplastic anemia.
    Blood. 2025;146:905-906.
    >> Share

  13. CARSON JL, Hebert PC, Alexander JH
    Counterpoint: the design and interpretation of blood transfusion randomized clinical trials.
    Blood. 2025;146:661-666.
    >> Share

    July 2025
  14. FATTIZZO B, Versino F, Barcellini W
    Breakthrough hemolysis in paroxysmal nocturnal hemoglobinuria throughout clinical trials: from definition to clinical practice.
    Blood. 2025;146:411-421.
    >> Share

  15. WANG Y, Yu L, Deng K, Packiarajan M, et al
    Novel, potent, and orally bioavailable LSD1 inhibitors induce fetal hemoglobin synthesis in a sickle cell disease mouse model.
    Blood. 2025;146:356-368.
    >> Share

  16. YU H, Signer RAJ
    Proteostasis disruption in inherited bone marrow failure syndromes.
    Blood. 2025;146:304-317.
    >> Share

  17. DUVAL R, Soudry A, De Oliveira Rios J, Linguet SL, et al
    The neutrophil antigen 3a/b polymorphism in SLC44A2 unexpectedly encodes the Csa/Csb red cell antigens.
    Blood. 2025;146:247-253.
    >> Share

  18. SETAYESH T, Chi M, Oestreicher Z, Sakabe M, et al
    A novel mouse model of hemoglobin SC disease reveals mechanisms underlying beneficial effects of hydroxyurea.
    Blood. 2025;146:13-28.
    >> Share

    June 2025
  19. ANDOLFO I, Iolascon A, Russo R
    The evolving landscape of hereditary stomatocytosis.
    Blood. 2025;145:3089-3100.
    >> Share

  20. LUZZATTO L, Nakao S
    Pathogenesis of paroxysmal nocturnal hemoglobinuria.
    Blood. 2025;145:3077-3088.
    >> Share

  21. GUERRA A, Lo Presti V, Chen DW, Martins AC, et al
    TNFalpha signaling restores steady-state hematopoiesis in a TNFalphaKO mouse model of anemia of inflammation.
    Blood. 2025 Jun 13:blood.2025029352. doi: 10.1182/blood.2025029352.
    >> Share

  22. SUN R, Srivastava A, Zapater JL, Njoku F, et al
    Diabetes mellitus and APOL1 genotype increase the risk for chronic kidney disease progression in sickle cell disease.
    Blood. 2025;145:2927-2930.
    >> Share

    May 2025
  23. POOL ES, Luk SJ, IJsselsteijn ME, van Unen V, et al
    Imaging Mass Cytometry Reveals the Order of Events in the Pathogenesis of Immune-Mediated Aplastic Anemia.
    Blood. 2025 May 22:blood.2025028723. doi: 10.1182/blood.2025028723.
    >> Share

  24. CHOU ST, Hendrickson JE
    How I treat challenging transfusion cases in sickle cell disease.
    Blood. 2025;145:2257-2265.
    >> Share

  25. BERI D, Rodriguez M, Singh M, McLaughlin D, et al
    Babesiosis and sickle red blood cells: loss of deformability, altered osmotic fragility, and hypervesiculation.
    Blood. 2025;145:2202-2213.
    >> Share

  26. GAO Z, Pan H, Zhang L, Li W, et al
    Targeting CD38 with Daratumumab for Platelet Transfusion Refractoriness in Aplastic Anemia.
    Blood. 2025 May 7:blood.2025029006. doi: 10.1182/blood.2025029006.
    >> Share

    April 2025
  27. FEDERTI E, Mattoscio D, Recchiuti A, Matte A, et al
    17(R)-Resolvin D1 protects against sickle cell-related inflammatory cardiomyopathy in humanized mice.
    Blood. 2025;145:1915-1928.
    >> Share

    March 2025
  28. WEEKS LD, Wilson AM, Naik RP, Efebera Y, et al
    Sickle cell trait does not cause "sickle cell crisis" leading to exertion-related death: a systematic review.
    Blood. 2025;145:1345-1352.
    >> Share

  29. GIBSON NM, Khandros E, Elgarten CW, Worster E, et al
    Impact of HLA Alloimmunization in Gene-Modified Autologous Stem Cell Transplant For Transfusion-Dependent Thalassemia.
    Blood. 2025 Mar 16:blood.2024027034. doi: 10.1182/blood.2024027034.
    >> Share

  30. IDRIS IM, Yusuf AA, Ismail II, Borodo AM, et al
    A Controlled Trial for Preventing Priapism in Sickle Cell Anemia: Hydroxyurea plus Placebo vs Hydroxyurea plus Tadalafil.
    Blood. 2025 Mar 12:blood.2024027898. doi: 10.1182/blood.2024027898.
    >> Share

  31. LONG Y, Zhang Q, Ling L, Zhuang Y, et al
    Mutations in AMBRA1 aggravate beta-thalassemia by impairing autophagy-mediated clearance of free alpha-globin.
    Blood. 2025;145:1074-1088.
    >> Share

    February 2025
  32. KULASEKARARAJ A, Griffin M, Piatek C, Shammo J, et al
    Long-term efficacy and safety of danicopan as add-on therapy to ravulizumab or eculizumab in PNH with significant EVH.
    Blood. 2025;145:811-822.
    >> Share

  33. DUCAMP S, Campagna DR, Sendamarai A, Schmidt P, et al
    X-linked sideroblastic anemia in females.
    Blood. 2025 Feb 5:blood.2024024475. doi: 10.1182/blood.2024024475.
    >> Share

    January 2025
  34. ABAZA Y, DeZern AE
    Imetelstat: a new addition to the therapeutic landscape of lower-risk MDS.
    Blood. 2025;145:469-474.
    >> Share


  35. Montoro J, Eikema D-J, Tuffnell J, et al. Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT. Blood. 2024;144(3):323-333.
    Blood. 2025;145:456.
    >> Share

  36. SU S, Bao W, Liu Y, Shi PA, et al
    IFN-I promotes T-cell-independent immunity and RBC autoantibodies via modulation of B-1 cell subsets in murine SCD.
    Blood. 2025;145:334-347.
    >> Share

  37. JAIN AG, Gerds AT
    How I Treat Anemia in Myelofibrosis.
    Blood. 2025 Jan 14:blood.2023022414. doi: 10.1182/blood.2023022414.
    >> Share

  38. CHANTHONG S, Charoenkwan P
    Parvovirus B19-induced autoimmune hemolytic anemia in hereditary elliptocytosis.
    Blood. 2025;145:141.
    >> Share

  39. ITO S, Chetlapalli K, Wang D, Potnis KC, et al
    Cost-effectiveness of iptacopan for paroxysmal nocturnal hemoglobinuria.
    Blood. 2025;145:127-140.
    >> Share

    December 2024
  40. SHARMA A
    How I treat sickle cell disease with gene therapy.
    Blood. 2024;144:2693-2705.
    >> Share

  41. COLE MA, Ranjan N, Gerber GF, Pan XZ, et al
    Complement biosensors identify a classical pathway stimulus in complement-mediated thrombotic microangiopathy.
    Blood. 2024;144:2528-2545.
    >> Share

  42. OLUWOLE O, Brunson AM, Adesina OO, Willen SM, et al
    Rates of strokes in Californians with sickle cell disease in the post-STOP era.
    Blood. 2024;144:2517-2527.
    >> Share

  43. CASTRUCCIO CASTRACANI C, Breda L, Papp TE, Guerra A, et al
    An erythroid-specific lentiviral vector improves anemia and iron metabolism in a new model of XLSA.
    Blood. 2024 Dec 10:blood.2024025846. doi: 10.1182/blood.2024025846.
    >> Share

  44. LANGER AL, Goggins BB, Esrick EB, Fell G, et al
    beta-Thalassemia minor is associated with high rates of worsening anemia in pregnancy.
    Blood. 2024 Dec 9:blood.2024026736. doi: 10.1182/blood.2024026736.
    >> Share

    November 2024
  45. KELLY C, Kumar R
    Pancreatitis-associated thrombotic microangiopathic hematolytic anemia with thrombocytopenia in a child.
    Blood. 2024;144:2270.
    >> Share

  46. CARUSO C, Cheng X, Michaud ME, Szafraniec HM, et al
    Less-deformable erythrocyte subpopulations biomechanically induce endothelial inflammation in sickle cell disease.
    Blood. 2024;144:2050-2062.
    >> Share

  47. CHOU ST, Mewha J, Friedman DF, Lazariu V, et al
    Genotyped RhD+ red cells for D-positive patients with sickle cell disease with conventional RHD and unexpected anti-D.
    Blood. 2024;144:2045-2049.
    >> Share

  48. ROMAN E, Fattizzo B, Shum MK, Hanna WT, et al
    Safety and efficacy of pegcetacoplan treatment for cold agglutinin disease and warm antibody autoimmune hemolytic anemia.
    Blood. 2024 Nov 1:blood.2023022549. doi: 10.1182/blood.2023022549.
    >> Share

    October 2024
  49. BAJEL A
    Anemia response in myelofibrosis revisited.
    Blood. 2024;144:1759-1760.
    >> Share

  50. BAUER DE
    Genetic medicine gestating for alpha-thalassemia.
    Blood. 2024;144:1554-1556.
    >> Share

  51. CHAPPELL ME, Breda L, Tricoli L, Guerra A, et al
    Use of HSC-targeted LNP to generate a mouse model of lethal alpha-thalassemia and treatment via lentiviral gene therapy.
    Blood. 2024;144:1633-1645.
    >> Share

  52. SHOPSOWITZ K, Moshref Razavi H
    A rare glimpse of Fessas bodies in a patient with beta-thalassemia major postsplenectomy.
    Blood. 2024;144:1543.
    >> Share

    September 2024
  53. VADIVELAN A, Doyle EK, Carson S, Denton C, et al
    Significant pituitary siderosis is common in transfusion-dependent sickle cell disease.
    Blood. 2024;144:1457-1459.
    >> Share

  54. DUCAMP S, Sendamarai AK, Campagna DR, Chin DWL, et al
    Murine models of erythroid 5ALA synthesis disorders and their conditional synthetic lethal dependency on pyridoxine.
    Blood. 2024;144:1418-1432.
    >> Share


  55. Transplant outcome in pediatric Fanconi anemia.
    Blood. 2024;144:1350.
    >> Share

  56. SATTY AM
    Fanconi anemia: realizing hematopoietic cure.
    Blood. 2024;144:1245-1246.
    >> Share

  57. NATANSON C, Applefeld WN, Klein HG
    Hemoglobin-based Transfusion Strategies for Cardiovascular - and Other Diseases: Restrictive, Liberal, or Neither?
    Blood. 2024 Sep 18:blood.2024025927. doi: 10.1182/blood.2024025927.
    >> Share

  58. KIM MG, Yu K, Yeh CY, Fouda R, et al
    Low-intensity transcranial focused ultrasound suppresses pain by modulating pain-processing brain circuits.
    Blood. 2024;144:1101-1115.
    >> Share

    August 2024
  59. PINTO VM, Mazzi F, De Franceschi L
    Novel therapeutic approaches in thalassemias, sickle cell disease, and other red cell disorders.
    Blood. 2024;144:853-866.
    >> Share

  60. KHANDROS E, Blobel GA
    Elevating fetal hemoglobin: recently discovered regulators and mechanisms.
    Blood. 2024;144:845-852.
    >> Share

  61. AMID A, Liu S, Babbs C, Higgs DR, et al
    Hemoglobin Bart's hydrops fetalis: charting the past and envisioning the future.
    Blood. 2024;144:822-833.
    >> Share

  62. TEFFERI A, Barosi G, Passamonti F, Hernandez-Boluda JC, et al
    Proposals for Revised International Working Group-European LeukemiaNet Criteria for Anemia Response in Myelofibrosis.
    Blood. 2024 Aug 8:blood.2024025802. doi: 10.1182/blood.2024025802.
    >> Share

  63. SHARMA A, Selukar S, Bi Y, Merlocco A, et al
    Impact of hematopoietic cell transplantation on myocardial fibrosis in young patients with sickle cell disease.
    Blood. 2024;144:672-675.
    >> Share

  64. WANG B, Shi D, Yang S, Lian Y, et al
    Mitochondrial tRNA pseudouridylation governs erythropoiesis.
    Blood. 2024;144:657-671.
    >> Share

  65. SPARKENBAUGH EM
    EPCR shedding light on sickle nephropathy.
    Blood. 2024;144:472-474.
    >> Share

  66. CHEN Q, Hazra R, Crosby D, Lenhart D, et al
    Heme-induced loss of renovascular endothelial protein C receptor promotes chronic kidney disease in sickle mice.
    Blood. 2024;144:552-564.
    >> Share

    July 2024

  67. Alternative donors in severe aplastic anemia.
    Blood. 2024;144:343.
    >> Share

  68. DEI ZOTTI F, Qiu A, D'Agati VD, Jagnarine S, et al
    Mitigation of Checkpoint Inhibitor-Induced Autoimmune Hemolytic Anemia through Modulation of Purinergic Signaling.
    Blood. 2024 Jul 16:blood.2024024230. doi: 10.1182/blood.2024024230.
    >> Share

  69. SZER J
    Thrombosis in PNH: largely gone, but not forgotten.
    Blood. 2024;144:125-126.
    >> Share

  70. GURNARI C, Awada H, Pagliuca S, Dima D, et al
    Paroxysmal nocturnal hemoglobinuria-related thrombosis in the era of novel therapies: a 2043-patient-year analysis.
    Blood. 2024;144:145-155.
    >> Share

  71. LUM SH, Eikema DJ, Piepenbroek B, Wynn R, et al
    Outcome of Hematopoietic Stem Cell Transplantation in 813 Pediatric Patients with Fanconi Anemia.
    Blood. 2024 Jul 5:blood.2023022751. doi: 10.1182/blood.2023022751.
    >> Share

  72. CORDEIL S, Jallades L
    Polycythemia revealing PIEZO1 hereditary xerocytosis.
    Blood. 2024;144:123.
    >> Share

    June 2024
  73. JACOBSOHN DA
    Dare mighty things for SCD.
    Blood. 2024;143:2569-2570.
    >> Share

  74. CHONAT S, Stowell SR
    COping with acute sickle cell hemolysis.
    Blood. 2024;143:2452-2453.
    >> Share

  75. NGUYEN KA, Matte A, Foresti R, Federti E, et al
    An oral carbon monoxide-releasing molecule protects against acute hyperhemolysis in sickle cell disease.
    Blood. 2024;143:2544-2558.
    >> Share

    May 2024
  76. BROTHERS RO, Turrentine KB, Akbar M, Triplett S, et al
    The influence of voxelotor on cerebral blood flow and oxygen extraction in pediatric sickle cell disease.
    Blood. 2024;143:2145-2151.
    >> Share

  77. SADLER KE, Price TJ
    A humanized focus on sickle cell pain.
    Blood. 2024;143:2016-2017.
    >> Share

  78. ALLISON RL, Welby E, Ehlers V, Burand A, et al
    Sickle cell disease iPSC-derived sensory neurons exhibit increased excitability and sensitization to patient plasma.
    Blood. 2024;143:2037-2052.
    >> Share

    April 2024
  79. MONTORO J, Eikema DJ, Tuffnell J, Potter V, et al
    Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT.
    Blood. 2024 Apr 21:blood.2024024173. doi: 10.1182/blood.2024024173.
    >> Share

  80. DEZERN AE
    A way to "mimic" the pathophysiology of acquired SAA.
    Blood. 2024;143:1318-1320.
    >> Share

  81. GORDEUK VR
    Glad tidings and joy for children with SCA.
    Blood. 2024;143:1326-1327.
    >> Share

    March 2024
  82. MAJUMDER R, Mohammad MA
    Sickle cell anemia: hepatic macrophages to the rescue.
    Blood. 2024;143:1209-1210.
    >> Share

  83. SILVESTRI L
    Ironing erythroid cells takes FLG1 and ERFE to tango.
    Blood. 2024;143:1208-1209.
    >> Share

  84. SZER J
    C5 inhibition in PNH: still effective and safe.
    Blood. 2024;143:1064-1065.
    >> Share

  85. KELLY RJ, Holt M, Vidler J, Arnold LM, et al
    Treatment outcomes of complement protein C5 inhibition in 509 UK patients with paroxysmal nocturnal hemoglobinuria.
    Blood. 2024;143:1157-1166.
    >> Share

  86. KASSIM AA, de la Fuente J, Nur E, Wilkerson K, et al
    An International Learning Collaborative Phase 2 Trial for Haploidentical Bone Marrow Transplant in Sickle Cell Disease.
    Blood. 2024 Mar 17:blood.2023023301. doi: 10.1182/blood.2023023301.
    >> Share

  87. NOGUCHI CT
    Hemolysis impairs sickle cell erythropoiesis.
    Blood. 2024;143:947-949.
    >> Share

  88. BENZ EJ JR, Silberstein LE, Panepinto J
    "Treatment with curative intent": the emergence of genetic therapies for sickle cell anemia.
    Blood. 2024;143:967-970.
    >> Share

  89. LIU W, Wu Y, Wei H, Ma J, et al
    Lactate administration improves laboratory parameters in murine models of iron overload.
    Blood. 2024;143:1045-1049.
    >> Share

  90. HAN Y, Gao C, Liu Y, Zhang H, et al
    Hemolysis-driven IFNalpha production impairs erythropoiesis by negatively regulating EPO signaling in sickle cell disease.
    Blood. 2024;143:1018-1031.
    >> Share

  91. COATES TD
    Higher hemoglobin is better in thalassemia.
    Blood. 2024;143:842-844.
    >> Share

  92. PAREKH DS, Eaton WA, Thein SL
    Recent developments in the use of pyruvate kinase activators as a new approach for treating sickle cell disease.
    Blood. 2024;143:866-871.
    >> Share

  93. MUSALLAM KM, Barella S, Origa R, Ferrero GB, et al
    Pretransfusion hemoglobin level and mortality in adults with transfusion-dependent beta-thalassemia.
    Blood. 2024;143:930-932.
    >> Share

  94. SAHA A, Palchaudhuri R, Lanieri L, Hyzy S, et al
    Alloengraftment without significant toxicity or GVHD in CD45 antibody-drug conjugate conditioned Fanconi anemia mice.
    Blood. 2024 Mar 6:blood.2023023549. doi: 10.1182/blood.2023023549.
    >> Share

    February 2024
  95. FOGERTY AE, Kuter DJ
    How I treat thrombocytopenia in pregnancy.
    Blood. 2024;143:747-756.
    >> Share

  96. JAMES AH, Strouse JJ
    How I treat sickle cell disease in pregnancy.
    Blood. 2024;143:769-776.
    >> Share

  97. ORTEL TL
    Introduction to a How I Treat series on hematologic complications in pregnancy.
    Blood. 2024;143:739-740.
    >> Share

  98. D'SA S, Vos JMI, Barcellini W, Wardecki M, et al
    Safety, tolerability, and activity of the active C1s antibody riliprubart in cold agglutinin disease: a phase 1b study.
    Blood. 2024;143:713-720.
    >> Share

  99. NINGTYAS DC, Leitner F, Sohail H, Thong YL, et al
    Platelets mediate the clearance of senescent red blood cells by forming prophagocytic platelet-cell complexes.
    Blood. 2024;143:535-547.
    >> Share

    January 2024
  100. BEN HAMZA A, Welters C, Stadler S, Bruggemann M, et al
    Virus-reactive T cells expanded in aplastic anemia eliminate hematopoietic progenitor cells by molecular mimicry.
    Blood. 2024 Jan 26:blood.2023023142. doi: 10.1182/blood.2023023142.
    >> Share

  101. GUIZOUARN H
    Mechanosensation and lipid scrambling news.
    Blood. 2024;143:300-301.
    >> Share


  102. Keith J, Christakopoulos GE, Fernandez AG, et al. Loss of miR-144/451 alleviates beta-thalassemia by stimulating ULK1-mediated autophagy of free alpha-globin. Blood. 2023;142(10):918-932.
    Blood. 2024;143:377.
    >> Share

  103. LIANG P, Zhang Y, Wan YCS, Ma S, et al
    Deciphering and disrupting PIEZO1-TMEM16F interplay in hereditary xerocytosis.
    Blood. 2024;143:357-369.
    >> Share

  104. NAMAZZI R, Bond C, Conroy A, Datta D, et al
    Hydroxyurea reduces infections in children with sickle cell anemia in Uganda.
    Blood. 2024 Jan 3:blood.2023021575. doi: 10.1182/blood.2023021575.
    >> Share

    December 2023
  105. HELLSTROM-LINDBERG ES, Kroger N
    Clinical decision-making and treatment of myelodysplastic syndromes.
    Blood. 2023;142:2268-2281.
    >> Share

  106. SHI H, Gao L, Kirby N, Shao B, et al
    Clearance of VWF by hepatic macrophages is critical for the protective effect of ADAMTS13 in sickle cell anemia mice.
    Blood. 2023 Dec 24:blood.2023021583. doi: 10.1182/blood.2023021583.
    >> Share

  107. SARDO U, Perrier P, Cormier K, Sotin M, et al
    The hepatokine FGL1 regulates hepcidin and iron metabolism during anemia in mice by antagonizing BMP signaling.
    Blood. 2023 Dec 24:blood.2023022724. doi: 10.1182/blood.2023022724.
    >> Share

  108. ATAGA KI
    The challenge of clinical end points in sickle cell disease.
    Blood. 2023;142:2047-2054.
    >> Share

    November 2023
  109. SPARKENBAUGH E, Little J
    Cold comfort in sickle cell disease.
    Blood. 2023;142:1854-1856.
    >> Share

  110. CAI J, Lee J
    Cold agglutinin syndrome with unexpected bone marrow CD5+ diffuse large B-cell lymphoma.
    Blood. 2023;142:1935.
    >> Share

  111. IVY ZK, Belcher JD, Khasabova IA, Chen C, et al
    Cold exposure induces vaso-occlusion and pain in sickle mice that depend on complement activation.
    Blood. 2023;142:1918-1927.
    >> Share

  112. DENTON CC, Vodala S, Veluswamy S, Hofstra TC, et al
    Splenic iron decreases without change in volume or liver parameters during luspatercept therapy.
    Blood. 2023;142:1932-1934.
    >> Share

    October 2023
  113. VAN DE KAR NCAJ, Wetzels JFM
    Narrowing the knowledge gap in atypical HUS.
    Blood. 2023;142:1334-1335.
    >> Share


  114. C5 inhibition in aHUS.
    Blood. 2023;142:1406.
    >> Share

  115. BROCKLEBANK V, Walsh PR, Smith-Jackson K, Hallam TM, et al
    Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort study.
    Blood. 2023;142:1371-1386.
    >> Share


  116. d'Humieres T, Saba J, Savale L, et al. Determinants of ventricular arrhythmias in sickle cell anemia: toward better prevention of sudden cardiac death. Blood. 2023;142(5):409-420.
    Blood. 2023;142:1329.
    >> Share

  117. WU Z, Young NS
    Single-cell genomics in acquired bone marrow failure syndromes.
    Blood. 2023;142:1193-1207.
    >> Share

    September 2023
  118. SALIBA AN, Musallam KM, Taher AT
    How I treat non-transfusion-dependent beta-thalassemia.
    Blood. 2023;142:949-960.
    >> Share

  119. BABBS C
    The incredible ULK improves beta-thalassemia.
    Blood. 2023;142:862-863.
    >> Share

  120. KEITH J, Christakopoulos GE, Fernandez AG, Yao Y, et al
    Loss of miR-144/451 alleviates beta-thalassemia by stimulating ULK1-mediated autophagy of free alpha-globin.
    Blood. 2023;142:918-932.
    >> Share

    August 2023
  121. GODLEY LA
    Germ line risk variants: beyond cancer.
    Blood. 2023;142:616-617.
    >> Share

  122. MOLTENI E, Bono E, Galli A, Elena C, et al
    Prevalence and clinical expression of germ line predisposition to myeloid neoplasms in adults with marrow hypocellularity.
    Blood. 2023;142:643-657.
    >> Share

  123. JAVA A, Atkinson J, Hu Z, Pozzi N, et al
    Mutations in atypical hemolytic uremic syndrome provide evidence for the role of calcium in complement factor I.
    Blood. 2023;142:607-610.
    >> Share

  124. DESAI AA
    Ventricular arrhythmias in sickle cell anemia.
    Blood. 2023;142:399-400.
    >> Share

    July 2023
  125. XI C, Pang J, Zhi W, Chang CS, et al
    Nrf2 sensitizes ferroptosis through l-2-hydroxyglutarate-mediated chromatin modifications in sickle cell disease.
    Blood. 2023;142:382-396.
    >> Share

  126. TUBMAN VN, Mohandas N, Abrams CS
    New ASH initiatives to improve patient care in the long-overlooked sickle cell disease.
    Blood. 2023;142:230-234.
    >> Share

  127. SIMONEAU J, Shah YM
    Ironing out beta-thalassemia during pregnancy.
    Blood. 2023;142:128-129.
    >> Share

  128. YU Y, Woloshun RR, Lee JK, Ebea PO, et al
    Fetal factors disrupt placental and maternal iron homeostasis in murine beta-thalassemia.
    Blood. 2023;142:185-196.
    >> Share

    June 2023
  129. BRAMMER JE, Ballen K, Sokol L, Querfeld C, et al
    Effective Treatment with the Selective Cytokine Inhibitor BNZ-1 Reveals the Cytokine Dependency of T-LGL Leukemia.
    Blood. 2023 Jun 23:blood.2022017643. doi: 10.1182/blood.2022017643.
    >> Share

  130. DEEG HJ
    Reward from half a match.
    Blood. 2023;141:3009-3010.
    >> Share

  131. TOLOSANO E
    Heme and macrophages: a complicated liaison.
    Blood. 2023;141:3015-3017.
    >> Share

  132. FERRER-VICENS I, Ferguson DCJ, Wilson MC, Heesom KJ, et al
    A novel human cellular model of CDA IV enables comprehensive analysis revealing the molecular basis of the disease phenotype.
    Blood. 2023;141:3039-3054.
    >> Share

  133. SHARMA R, Antypiuk A, Vance SZ, Manwani D, et al
    Macrophage metabolic rewiring improves heme-suppressed efferocytosis and tissue damage in sickle cell disease.
    Blood. 2023;141:3091-3108.
    >> Share

  134. LAM WK, Yip SF
    Cytopenic AML with marrow fibrosis and multihit TP53 abnormalities.
    Blood. 2023;141:3006.
    >> Share

  135. DEAN A
    Help on the way to unsilence HbF.
    Blood. 2023;141:2670-2672.
    >> Share

  136. DEAN A
    Help on the way to unsilence HbF.
    Blood. 2023;141:2670-2672.
    >> Share

    May 2023
  137. BENJAMIN RJ
    Cytosolic antigens prime RBC alloantibodies.
    Blood. 2023;141:2550-2551.
    >> Share

  138. D'HUMIERES T, Saba J, Savale L, Dupuy M, et al
    Determinants of Ventricular Arrhythmias in Sickle Cell Anemia: Towards a Better Prevention of Sudden Cardiac Death.
    Blood. 2023 May 22:blood.2022019571. doi: 10.1182/blood.2022019571.
    >> Share

  139. HESLOP HE
    Introduction to a How I Treat series on emergent CAR T-cell toxicities.
    Blood. 2023;141:2405-2407.
    >> Share

    April 2023
  140. LI C, Georgakopoulou A, Newby GA, Chen PJ, et al
    In vivo HSC prime editing rescues sickle cell disease in a mouse model.
    Blood. 2023;141:2085-2099.
    >> Share

  141. GUTIERREZ-RODRIGUES F, Munger E, Ma X, Groarke EM, et al
    Differential diagnosis of bone marrow failure syndromes guided by machine learning.
    Blood. 2023;141:2100-2113.
    >> Share

  142. DEZERN A, Zahurak ML, Symons HJ, Cooke KR, et al
    Alternative donor BMT with post-transplant cyclophosphamide as initial therapy for acquired severe aplastic anemia.
    Blood. 2023 Apr 21:blood.2023020435. doi: 10.1182/blood.2023020435.
    >> Share

  143. LANGER AL
    Love's labor's lost? Fetal vs maternal AIHA outcomes.
    Blood. 2023;141:1906-1907.
    >> Share

  144. GURNARI C, Prata PH, Catto LFB, Durmaz A, et al
    IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria.
    Blood. 2023 Apr 13:blood.2023020108. doi: 10.1182/blood.2023020108.
    >> Share

  145. SHET AS
    FXII and sickle cell: the clot thickens.
    Blood. 2023;141:1787-1789.
    >> Share

  146. RISITANO AM
    PNH and complement gene variants.
    Blood. 2023;141:1780-1782.
    >> Share

  147. SPARKENBAUGH EM, Henderson MW, Miller-Awe M, Abrams C, et al
    Factor XII contributes to thrombotic complications and vaso-occlusion in sickle cell disease.
    Blood. 2023;141:1871-1883.
    >> Share

  148. PRATA PH, Galimard JE, Sicre de Fontbrune F, Duval A, et al
    Rare germline complement factor H variants in patients with paroxysmal nocturnal hemoglobinuria.
    Blood. 2023;141:1812-1816.
    >> Share


  149. Walter O, Cougoul P, Maquet J, et al. Risk of vaso-occlusive episode after exposure to corticosteroids in patients with sickle cell disease. Blood. 2022;139(26):3771-3777.
    Blood. 2023;141:1778.
    >> Share

    March 2023
  150. SUKUMAR S, Sasa G
    Blocking COX unlocks response in GHDD.
    Blood. 2023;141:1497-1498.
    >> Share

  151. BROWN TJ, Barrett N, Meng H, Ricciotti E, et al
    Nonsteroidal anti-inflammatory drugs as a targeted therapy for bone marrow failure in Ghosal hematodiaphyseal dysplasia.
    Blood. 2023;141:1553-1559.
    >> Share

  152. ODAME I
    HU for SCA in Africa: associated malaria benefit.
    Blood. 2023;141:1370-1371.
    >> Share

  153. HAKKARAINEN M, Kaaja I, Douglas SPM, Vulliamy TJ, et al
    The Clinical Picture of the ERCC6L2 Disease - from Bone Marrow Failure to Acute Leukemia.
    Blood. 2023 Mar 23:blood.2022019425. doi: 10.1182/blood.2022019425.
    >> Share

  154. HAMMOUDI N, Lionnet F
    Heart failure in SCA: still challenging.
    Blood. 2023;141:1248-1249.
    >> Share

  155. AYOUB PG, Kohn DB
    beta-Thalassemia: all about that base, no cutting.
    Blood. 2023;141:1098-1099.
    >> Share

  156. MATSON DR, Matkovic E
    Peripheral erythrophagocytosis in paroxysmal cold hemoglobinuria.
    Blood. 2023;141:1233.
    >> Share

  157. HARDOUIN G, Antoniou P, Martinucci P, Felix T, et al
    Adenine base editor-mediated correction of the common and severe IVS1-110 (G>A) beta-thalassemia mutation.
    Blood. 2023;141:1169-1179.
    >> Share


  158. Ludwig LS, Lareau CA, Bao EL, et al. Congenital anemia reveals distinct targeting mechanisms for master transcription factor GATA1. Blood. 2022;139(16):2534-2546.
    Blood. 2023;141:1094.
    >> Share

  159. FAKHOURI F, Schwotzer N, Fremeaux-Bacchi V
    How I diagnose and treat atypical hemolytic uremic syndrome.
    Blood. 2023;141:984-995.
    >> Share

    February 2023
  160. QUINN CT
    Hydroxyurea: how much is enough?
    Blood. 2023;141:813-814.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016